Pharmacotherapy for Parkinson's disease: current options, promising future therapies.
作者信息
Moser Sharon S, Besler-Panos Wendy
机构信息
University of Detroit, Mercy College of Health Professions, Physician Assistant Program, Detroit, Mich, USA.
出版信息
JAAPA. 2006 Aug;19(8):38-44. doi: 10.1097/01720610-200608000-00007.
Abstract
摘要
相似文献
1
Pharmacotherapy for Parkinson's disease: current options, promising future therapies.
JAAPA. 2006 Aug;19(8):38-44. doi: 10.1097/01720610-200608000-00007.
2
Medications for Parkinson's disease.
Neurologist. 2007 Nov;13(6):387-8. doi: 10.1097/NRL.0b013e318158e47d.
3
Peak-dose dyskinesia; an acceptable price for mobility in late-stage Parkinson's disease?
Clin Neurophysiol. 2005 Sep;116(9):1997-8. doi: 10.1016/j.clinph.2005.06.009.
4
[Diagnosis and therapy of Parkinson's disease].
MMW Fortschr Med. 2005 May 17;147 Spec No 2:28-31.
5
Drugs for Parkinson's disease.
Treat Guidel Med Lett. 2011 Jan;9(101):1-6; quiz 2 p following 6.
6
Recent advances in Parkinson's disease.
Ideggyogy Sz. 2002 Nov 20;55(11-12):406-7.
7
Waking up to sleep episodes in Parkinson's disease.
Mov Disord. 2000 Mar;15(2):212-5. doi: 10.1002/1531-8257(200003)15:2<212::aid-mds1002>3.0.co;2-6.
8
[Parkinson's disease].
Ryoikibetsu Shokogun Shirizu. 1999(27 Pt 2):5-14.
9
Addiction as aberrant learning-evidence from Parkinson's disease.
Addiction. 2012 Feb;107(2):248-50. doi: 10.1111/j.1360-0443.2011.03624.x.
10
Rehabilitation goals and strategies in Parkinson's disease.
Eur J Phys Rehabil Med. 2009 Jun;45(2):205-8.
引用本文的文献
1
Overexpression of lentivirus-mediated glial cell line-derived neurotrophic factor in bone marrow stromal cells and its neuroprotection for the PC12 cells damaged by lactacystin.
Neurosci Bull. 2007 Mar;23(2):67-74. doi: 10.1007/s12264-007-0010-5.
Zotero 插件